Class II
Ongoing
Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 mg, 60 Tablets per Bottle, Rx only, Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridg…
Why: CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.
- Company
- Boehringer Ingelheim Pharmaceuticals, Inc.
Ridgefield, CT, United States - Reported
- Jul 8, 2026
- Recall started
- Jun 12, 2026
- Where sold
- OH
- Amount
- 560 bottles
- Full product description
- Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 mg, 60 Tablets per Bottle, Rx only, Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA. NDC: 00597-0300-45
- Lots / codes affected
- Lot 3244413; Exp. 12/31/2028
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.